Palliative wound care reframes the goal from healing to comfort. This guide covers the symptom-focused approach to malignant wounds, terminal pressure injuries, and Kennedy ulcers in patients receiving hospice or palliative services.
Healix360 supports access to advanced mobile wound care services across Southern California and the Las Vegas metropolitan area. Care is coordinated and provided directly by licensed physicians and nurse practitioners experienced in the evaluation and management of chronic and complex wounds — including the unique wound types encountered at end of life. Our model emphasizes that meaningful wound care does not stop when curative goals shift to comfort. For hospice and palliative patients, the focus simply changes: from closure to dignity, from healing to symptom control, from aggressive intervention to quiet presence.
Palliative wound care is defined as the holistic management of wounds in patients with advanced, life-limiting illness, where the primary goals are symptom control — pain, odor, exudate, bleeding, and psychosocial distress — rather than wound closure. The standard of care prioritizes patient comfort, family education, and quality of life over healing trajectories that may not be biologically achievable in the time the patient has left. Done well, palliative wound care can dramatically improve the final weeks of a patient's life and reduce the burden on family and caregivers.
The single most important conceptual shift in palliative wound care is recognizing that wound closure may not be possible — and that pursuing closure when it is not biologically achievable can cause harm. Patients in the last weeks of life typically experience progressive cachexia, hypoperfusion, organ failure, and immune compromise that make wound healing physiologically impossible. Aggressive debridement, frequent dressing changes, and pressure of repositioning can all increase suffering without improving outcomes. The clinician's job is to honor that reality and pivot the plan.
This pivot does not mean abandoning the wound. On the contrary, palliative wound care often requires more clinical judgment than curative care, because the clinician must continually balance comfort, family wishes, dignity, and the realistic trajectory of the underlying illness. The Wound, Ostomy and Continence Nurses Society (WOCN) and the American Academy of Hospice and Palliative Medicine endorse a structured approach centered on symptom control rather than measurable wound progression.
If a wound cannot heal, the question is no longer 'how do we close it?' — it is 'how do we make this patient comfortable, this room livable, and this family supported?'
Palliative wound care organizes around five primary symptom domains. Each requires its own assessment, intervention, and reassessment cadence. The acronym some clinicians use is PEBOP: Pain, Exudate, Bleeding, Odor, and Psychosocial impact.
Wound pain in palliative patients is often undertreated, in part because clinicians focus on systemic pain regimens without addressing the local procedural pain of dressing changes. A practical approach combines a stable systemic regimen — typically opioids titrated by the hospice team — with pre-procedural breakthrough dosing, atraumatic dressing selection, and gentle technique. Topical morphine in a hydrogel base (commonly compounded as 10 mg morphine sulfate in 8 g of Intrasite or similar hydrogel) has Cochrane-level evidence for reducing localized wound pain in malignant ulcers.
Excessive wound exudate at end of life is common and creates a cascade of secondary problems: maceration of surrounding skin, soiled clothing and bedding, increased odor, and constant disruption from dressing changes. The dressing hierarchy moves from foams to super-absorbent dressings to specialty containment depending on volume.
Wound odor is one of the most distressing symptoms for both patient and family, and it is consistently rated higher than pain on quality-of-life surveys in patients with malignant wounds. Odor in palliative wounds is typically driven by anaerobic bacterial overgrowth in necrotic tissue. Management combines antimicrobial dressings, environmental measures, and sometimes systemic agents.
Topical metronidazole has been shown in multiple Cochrane-reviewed studies to reduce malignant wound odor within 3 to 7 days, often dramatically improving patient willingness to receive visitors.
Fungating malignant wounds — most commonly arising from breast, head and neck, or melanoma malignancies — are highly vascular and prone to bleeding. Minor capillary ooze can usually be managed with non-adherent dressings and gentle technique. Larger bleeds may require topical hemostatic agents or, rarely, palliative radiation or embolization. Major hemorrhage from a carotid blowout or eroded vessel is a medical emergency with specific palliative protocols that families and home caregivers should be prepared for in advance.
"Preparing a family for the possibility of bleeding is one of the most compassionate things we do. Surprise is the enemy of dignity at the bedside." — Healix360 Clinical Team
Kennedy terminal ulcers (KTUs) are sacral or buttock ulcers that appear suddenly in patients within days to weeks of death. They typically present as butterfly-, pear-, or horseshoe-shaped lesions with rapid onset, irregular borders, and red-yellow-black discoloration. Unlike standard pressure injuries, KTUs are widely understood to represent skin failure as part of multi-organ system failure at the end of life — they are not preventable through repositioning alone, and their appearance often signals a prognosis measured in days. Documentation should reflect the KTU pattern to avoid mischaracterization as a preventable pressure injury.
The SCALE (Skin Changes At Life's End) consensus statement, published by an international expert panel, formalized the recognition that skin, like any other organ, can fail at the end of life. SCALE skin changes can include sudden mottling, eschar formation without preceding pressure injury, and rapidly evolving sacral discoloration. Recognizing SCALE phenomena spares families guilt about 'preventable' wounds and refocuses the team on comfort.
Fungating wounds arise from cutaneous extension of underlying malignancy — most often breast, head and neck, melanoma, sarcoma, or vulvar cancers. They are typically friable, malodorous, exudative, and prone to bleeding. Closure is not biologically achievable, so the entire focus is on the five symptom domains: pain, exudate, bleeding, odor, and psychosocial impact. Topical metronidazole, super-absorbent dressings, and ostomy-style containment are mainstays.
Patients in the final weeks of life often develop pressure injuries that are unavoidable despite excellent care. Cachexia, hypoperfusion, immobility, and tissue hypoxia conspire to produce skin breakdown that no repositioning schedule can prevent. The NPIAP recognizes the concept of unavoidable pressure injuries in this context. The treatment goal is symptom control and dignified containment, not closure.
Families bear most of the day-to-day burden of palliative wound care at home. They need clear, written instructions, realistic expectations, and the explicit reassurance that the wound is not a failure of their care. Many family caregivers carry deep guilt about visible wounds, particularly when a hospice agency frames the wound in clinical-curative language. A skilled palliative wound clinician spends as much time educating family as treating the wound.
Palliative wound care does not happen in isolation. It requires close coordination with the hospice interdisciplinary team — physician, nurse case manager, social worker, chaplain, home health aide, and pharmacist. The Healix360-coordinated wound specialist functions as a clinical adjunct to the existing hospice team, providing wound expertise, advanced dressing selection, and procedural skills (such as bedside debridement of necrotic tissue when comfort is the goal) without disrupting the hospice plan of care.
Wound care for hospice patients raises specific reimbursement questions because the Medicare hospice benefit covers all care related to the terminal diagnosis. When a wound is related to the terminal diagnosis (such as a fungating breast cancer wound in a patient on hospice for breast cancer), wound care is included in the hospice per-diem and provided by the hospice team. When a wound is unrelated to the terminal diagnosis (for example, a chronic venous leg ulcer in a patient on hospice for end-stage heart failure), Medicare Part B may cover specialist evaluation and management outside the hospice benefit. Healix360-coordinated clinicians work closely with the hospice agency to clarify the relationship and the appropriate billing pathway before the visit.
Palliative wound care is, in the deepest sense, witnessing work. The clinician sits with families through some of the hardest moments of their lives — the husband whose wife's breast tumor has eroded through the chest wall, the daughter changing her father's sacral dressing while he sleeps. Technical skill matters, but presence matters more. The best palliative wound clinicians blend evidence-based interventions with quiet, unhurried attention.
Healix360 coordinates palliative and hospice-adjunct wound care visits in the patient's home, hospice residence, assisted living apartment, or skilled nursing facility throughout Los Angeles, Orange, Riverside, San Bernardino, Ventura, Santa Barbara, Kern, San Luis Obispo, San Diego, Clark, and Nye counties. We work alongside Medicare-certified hospice agencies and palliative care programs to provide consultative wound expertise without duplicating services. Headquartered in Glendale, California, our intake team verifies benefits, confirms relationship to the terminal diagnosis with the hospice agency, and schedules visits — often the same week as referral.
If a patient on hospice or palliative care has a wound that is causing distress — pain, odor, exudate, or bleeding — call Healix360 at 877-545-1300. Our clinicians coordinate seamlessly with your hospice team and bring symptom-focused wound expertise to the bedside.
Palliative wound care is the holistic management of wounds in patients with advanced, life-limiting illness, where the primary goal is symptom control rather than wound closure. It focuses on five symptom domains: pain, exudate, bleeding, odor, and psychosocial impact. The approach acknowledges that healing may not be biologically achievable and reframes success as patient comfort, family support, and dignity at the end of life.
Many are, but some are not. The SCALE (Skin Changes At Life's End) consensus statement and NPIAP both recognize that skin can fail as part of multi-organ failure in the dying process. Kennedy terminal ulcers, in particular, are widely understood as a marker of impending death rather than a preventable nursing failure. Reframing unavoidable wounds for family caregivers reduces guilt and refocuses energy on comfort.
A Kennedy terminal ulcer is a sacral or buttock skin lesion that appears suddenly in patients within days to weeks of death. It typically presents as a butterfly-, pear-, or horseshoe-shaped lesion with irregular borders and red, yellow, and black discoloration. KTUs are believed to represent skin failure as part of the dying process and are not preventable through repositioning alone. Their recognition is important to spare families inappropriate guilt and to signal that prognosis is short.
Topical metronidazole gel (0.75 percent or 0.8 percent) applied directly to the wound bed at each dressing change is the most evidence-supported intervention. Systemic oral metronidazole, activated charcoal dressings, and silver-impregnated antimicrobial dressings are also commonly used. Environmental measures — activated charcoal trays, room ventilation — help. Heavy fragrances or essential oils generally make the experience worse and should be avoided.
A stable systemic opioid regimen managed by the hospice team is the foundation. For procedural pain at dressing changes, breakthrough opioid is given 30 to 60 minutes before the change, atraumatic soft silicone dressings are used, and adherent dressings are soaked off rather than peeled. Topical morphine in a hydrogel base has Cochrane-level evidence for localized wound pain in malignant ulcers. Reducing dressing change frequency to the minimum compatible with comfort is also important.
It depends on whether the wound is related to the terminal diagnosis. If the wound is related — for example, a fungating breast cancer wound in a patient on hospice for breast cancer — wound care is included in the Medicare hospice benefit and provided by the hospice team. If the wound is unrelated to the terminal diagnosis, Medicare Part B may cover specialist evaluation and management outside the hospice benefit. Healix360 verifies the relationship with the hospice agency before each visit.
Yes, with proper teaching. Most palliative wound dressings are designed for atraumatic, less-frequent changes specifically so that family caregivers can manage them. The Healix360 clinician demonstrates the dressing change in person, provides written step-by-step instructions, ensures the family has supplies, and is available by phone for questions. Hospice nurses also provide ongoing teaching and support between specialist visits.
Apply gentle, sustained pressure with a clean towel for 10 to 15 minutes. Use dark-colored towels (often pre-positioned by the hospice team) to reduce visual alarm. Call the hospice nurse on the after-hours line immediately. For known high-risk situations such as carotid blowout, the hospice team typically pre-positions a crisis kit with rapid-acting opioid and benzodiazepine, and the family is taught the protocol in advance. Surprise is the enemy of dignity, so anticipation and preparation matter.
A fungating wound is one caused by cutaneous extension of an underlying malignancy — most commonly breast, head and neck, melanoma, sarcoma, or vulvar cancers. Fungating wounds are typically friable, malodorous, exudative, and prone to bleeding. Closure is not biologically achievable while the underlying tumor is active, so the entire focus is symptom control: pain management, odor reduction with topical metronidazole, exudate containment with super-absorbent or ostomy-style dressings, and bleeding precautions.
Repositioning should be guided by patient comfort, not a rigid schedule. In actively dying patients, moving every two hours can cause more pain than benefit and is no longer the standard. The hospice and palliative care literature now supports an individualized approach — repositioning when the patient is comfortable enough to tolerate it, using support surfaces to reduce pressure between turns, and accepting that some skin breakdown is unavoidable in this phase. The wound specialist can help families and aides find this balance.
Healix360-coordinated clinicians function as a consultative wound specialty resource for the hospice interdisciplinary team. We provide procedural skills (bedside debridement when comfort-appropriate), advanced dressing selection, topical compounding recommendations, and family education — without duplicating services already provided by the hospice nurse case manager, aide, social worker, or chaplain. Communication with the hospice agency is built into every visit.
Call Healix360 at 877-545-1300, or have your hospice nurse, palliative care physician, or family caregiver submit a referral. Our intake team verifies benefits, confirms the wound's relationship to the terminal diagnosis with the hospice agency, and coordinates the visit at the patient's home, hospice residence, assisted living apartment, or skilled nursing facility throughout our nine Southern California counties and the Las Vegas metropolitan service area. Most visits occur within the same week as referral.
Call 877-545-1300 or request a provider to begin care. Healix360 serves Southern California and Nevada and accepts Medicare Part B and most major insurance plans.